XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
XORTX Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.01−0.23 (-18.55%)
Close on Oct 19, 2026
Share price
−$4.49 (−81.64%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Diluted shares
- 5M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Eight years at a glance
Fiscal years 2018 to 2025, CAD
Reported period